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ACucumbergreenmottlemosaicvirus(CGMMV)wasusedtopresentatruncateddenguevirustype2envelope(E)proteinbinding
region from amino acids 379 to 423 (EB4). The EB4 gene was inserted at the terminal end of the CGMMV coat protein (CP)
open reading frame (ORF). Read-through sequences of TMV or CGMMV, CAA-UAG-CAA-UUA, or AAA-UAG-CAA-UUA were,
respectively, inserted in between the CP and the EB4 genes. The chimeric clones, pRT, pRG, and pCG+FSRTRE, were transcribed
into full-length capped recombinant CGMMV transcripts. Only constructs with the wild-type CGMMV read-through sequence
yieldedinfectiousvirusesfollowinginfectionofhostplant,muskmelon(Cucumis melo)leaves.Theratioofmodiﬁedtounmodiﬁed
CP for the read-through expression clone developed was also found to be approximately 1:1, higher than what has been previously
reported. It was also observed that infectivity was not aﬀected by diﬀerences in pI between the chimera and its wild counterpart.
Analysis of recombinant viruses after 21-days-postinculation (dpi) revealed that deletions occurred resulting in partial reversions
of the viral population to near wild type and suggesting that this would be the limiting harvest period for obtaining true to type
recombinants with this construct.
Copyright © 2009 Pak-Guan Teoh et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The development of plant virus vectors as in planta expres-
sion systems for foreign genes provides an attractive alter-
native biotechnological approach for peptide expression [1–
5]. This method has been exploited in vaccine production,
where small foreign peptides are expressed as a fusion with
the viral coat proteins. Essentially, an insertion site has to be
determined in the virus genome so that the resulting product
will be displayed on the surface of the virus particle which
is then propagated in plants and consequently isolated and
used as antigen presenting vehicles [5, 6]. Modiﬁcations that
do not interfere with the normal functions of the particular
virus are a prerequisite for this peptide fusion approach. One
strategysuggeststhatforeigngenesegmentscouldbefusedto
theterminusofaviralgenein awaythatpermitstheproduc-
tion of both the fusion product and the native viral protein,
thus avoiding interference with normal gene functions. The
success of this epitope presentation strategy depends on a
detailed knowledge of virus structure at the atomic level,
which is only available for a limited number of viruses.
We have recently developed Cucumber green mottle
mosaic virus (CGMMV) as a candidate for expressing anti-
genic peptides in plants [7]. CGMMV is a tobamovirus with
ag e n o m es i z eo f∼6.4kb which has been well characterized
both biologically [8, 9] and structurally [10, 11]. In this
study, a truncated dengue virus type 2 envelope (E) protein
binding region from amino acid 379 to 423 (EB4) was
inserted into the end of the coat protein (CP) open reading
frame (ORF) of a previously constructed CGMMV full-
length clone, pCGT7X [7]. The antigenic peptide was chosen
based on a recent study that suggests its importance in
enabling dengue virus to bind to speciﬁc host cell receptors
(S. Abu Bakar personal communication). The present study
explores the possibility of extrapolating the CGMMV anti-
genic epitope presentation system for developing diagnostics2 Journal of Biomedicine and Biotechnology
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Figure 1: Position of primers in constructed plasmid clones.
Primers 4–8 were used to amplify the EB4 gene from pCANTAB
5E. Plasmid pCGT7X and ampliﬁed EB4 fragments were digested
with HindIII and ligated together to obtain the respective plasmid
clones as shown. HindIII is the insertion site of EB4 at the end of
CGMMV CP. PCR ampliﬁcation using primer pairs 1–9, 3–9, and
2–7 will yield ampliﬁed products of approximately 6.5kb, 0.85kb,
a n d2 . 2k b ,r e s p e c t i v e l y .
and potentially therapeutics against dengue. The study was
also used to challenge the size limits of foreign gene insertion
intotheCGMMVvectorasinthepreviousstudythehepatitis
B surface antigen (HBsAg) used was only 33 amino acids [7].
2.MaterialsandMethods
2.1. The Antigenic Epitope. The 45 amino acid-long EB4
protein used in this study has been previously shown to
react with the dengue-speciﬁc antibody 3H5-1 (S. Abu Bakar
personal communication).
2.2. Construction of Chimeric CGMMV Vector. The EB4
coding sequence was ampliﬁed from a pCANTAB 5E vector
carryingthevirusgeneusing3primerpairsets.Theresulting
PCR products were puriﬁed then digested overnight with
HindIII restriction endonuclease, with the same treatment
carried out on the full-length clone of CGMMV (pCGT7X,
∼9.0kb) previously constructed [7]. The digested PCR
productsandthelinearized pCGT7X werepuriﬁed following
1%agarosegelelectrophoresis,andthenligatedtoformpRT,
pRG, both containing the TMV read-through sequence [12]
and pCG+FSRTRE (containing the CGMMV read-through
sequence) [13], respectively (Figure 1). The three primer sets
used in the ampliﬁcations were as follows.
Forward RT (5 -CCAAGCTTGCCAATAGCAATTAAT-
CATAGGAGTAGAGC-3 )a n dR e v e r s eE( 5  -CCAAGC-
TTCTCCAAAATCCCAAGCTGT-3 ) for construction of
clone pRT, Forward (RT) TGG (5 -AAGCTTGGCAATAGC-
AATTAATCATAGGAGTAGAGCCG-3 )andR ev erseQ(5  -
CCAAGCTTGTCCAAAATCCCAAGCTGTGT-3 ) for clone
pRG, and Forward SRT (5 -CCAAGCTTCCAAATAGCA-
ATTAATCATAGGAGTAGAGCCG-3 )a n dR e v e r s eE( 5  -
CCAAGCTTCTCCAAAATCCCAAGCTGT-3 ) for clone
pCG+FSRTRE.
2.3. Production of Infectious RNA. The templates used
in the in vitro transcription reactions were synthesized
through long-distance PCR (LD-PCR) in 50μLP C Rc o c k -
tails containing 1X HF Buﬀer of Phusion DNA Poly-
merase (Finnzymes, Espoo, Finland) with 1.5mM MgCl2
(Finnzymes, Espoo, Finland), 0.2mM dNTP mix, 0.5μM
forward primer, CGT7dG (5 -CCGAGCTCGTAATAC-
GACTCACTATAGGTTTTA-3 ), 0.5μM reverse primer,
CGMMV 3 -UTR (5 -TGGGCCCCTACCCGGGGAAAA-
GGGGGGAT-3 ), 10–20ng of DNA template, and 1U of
Phusion DNA Polymerase (Finnzymes, Espoo, Finland).
The reaction was set up in 0.2mL tubes, and the thermal
cycling was conducted with initial denaturation at 98◦C
for 60 seconds, followed by 30 cycles of 98◦C denaturation
for 10 seconds, annealing at 63◦C for 20 seconds and
elongation at 72◦C for 1 minute and 50 seconds, and ﬁnally
an extension step at 72◦C for 5 minutes. The ampliﬁed
product was puriﬁed through phenol-chloroform extraction
followed by ethanol precipitation. The pellet was dissolved
in an appropriate volume of RNase-free distilled water to
1μg/μLa n ds t o r e da t−20◦C till further use. The in vitro
transcriptionwascarriedoutusingthe(Ambion,Calif,USA)
High Yield Capped T7 RNA Transcription Kit according
to the manufacturer protocol. Aliquots of the in vitro-
synthesized transcripts were denatured and electrophoresed
alongside RNA markers showing its integrity and the
expected transcript size of approximately 6.5kb. Since no
DNase I treatment was done, traces of DNA template of the
transcription reactions were detected.
2.4. Maintaining the Host Plants. Muskmelon (C. melo)
plants were used as host plants for virus propagation. Plants
used in this study were maintained in a growth room at 25◦C
with 16 hours of light and 8 hours of darkness. Healthy 10-
day-old plantlets with cotyledons and small ﬁrst leaf were
used for inoculation.
2.5. Inoculation with RNA Transcripts. One transcription
reaction was used to inoculate 2 plantlets by gently rubbing
the reaction mixture over carborundum-dusted ﬁrst leaf and
cotyledons of 10-day-old plantlets. Mock inoculation was
done by gently rubbing distilled water onto carborundum-
dusted ﬁrst leaves. The excess inoculum was rinsed oﬀ
using distilled water from the leaf surfaces 60 minutes after
inoculation.
2.6. RT-PCR Detection of Chimeric Virus Infection. Total
RNA was isolated from the new leaf of the inoculated andJournal of Biomedicine and Biotechnology 3
healthy plants using RNeasy Plant Mini Kit (QIAGEN).
RT-PCR was performed using AccuPower RT/PCR PreMix
(Bioneer, Daejeon, South Korea) with primers CGMMV
3 UTR (5 -TGGGCCCCTACCCGGGGAAAAGGGGGG-
AT-3 )p a i r e dw i t hPst Is e n s e( 5  -TAGGAAAAAACC-
AGAAGATCTGCAGGAATTTTTCTC-3 ) or C5500F (5 -
GTCGCTACAACTAACTCTATTATCAAAAAGGGTC-3 ).
Reactions were carried out according to the manufacturer
protocols. Infected plants will give a PCR-ampliﬁed product
of approximately 2.2kb (with PstIs e n s ea n dC G M M V
3 UTR primers) or 0.85kb (with C5500F and CGMMV
3 UTR primers). RT-PCR reactions were carried out for
plants at 14, 21, and 30 day-postinoculation (dpi).
2.7. Virus Puriﬁcation. Plant virus isolation procedures used
in this study were modiﬁed from [8]. Infected plants
showing typical symptoms were harvested, weighed, and
homogenized in ice-cold 0.1M phosphate buﬀer (pH 7.0
containing 1% of β-mercaptoethanol) at 1mL/g of plant
material for 10 minutes using a mechanical blender. The
homogenate was ﬁltered through 2 layers of cheesecloth
and then mixed with equal volume of chloroform:butanol
(1:1). The mixture was then stirred for 1-2 hours at room
temperature and then the organic phase was separated from
the mixture through centrifugation at 8000g for 15 minutes.
The aqueous layer was transferred to a beaker, 100mL of
NaCl (4g/L) and PEG6000 added, and the mixture stirred on
ice for 1 hour. The precipitated virus was separated from the
solution through centrifugation at 10000g for 30 minutes
at 4◦C. The resulting pellet was reconstituted in 10mL of
0.1M phosphate buﬀer pH 7.0. Any undissolved material
was cleared by centrifugation at 10000g for 30 minutes at
12◦C. Then 0.2M EDTA (pH 7) (50mL/L) was added to
the supernatant and the mixture subjected to centrifugation
at 110000g for 90 minutes at 4◦C. The supernatant was
discarded, and the pellet was left to air dry. The virus pellet
was then reconstituted in 100μL of distilled water and stored
at 4◦C until used.
2.8. Analyses of Viral Genome. Analyses of sequences of the
ampliﬁed products were carried using BioEdit Sequence
AlignmentEditorSoftware(version6.0.5)(http://www.mbio
.ncsu.edu/BioEdit/bioedit.html). The pI and charge values of
the coat protein were calculated using the protein calculator
developedbyChrisPutnamofTheScrippsResearchInstitute
(http://www. scripps.edu/∼cdputnam/protcalc.html).
3. Results
3.1. Infectivity of Constructed Transcription Clones—Read-
Through Sequence Preference. In this study, the chimeric
CGMMV vectors pRT, pRG, and pCG-FSRTRE were con-
structed by inserting the EB4 coding sequence to the end
of the CGMMV CP ORF in plasmid pCGT7X. The maps of
these constructed clones are shown in Figure 1, which indi-
cates their respective position of the primers during ampli-
ﬁcation and cloning procedures. Maps of plasmids pCGT7X
are carrying the wild-type CGMMV, and pCANTAB 5E are
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Figure 2: A representative gel image of pCG+FSRTRE-derived
transcripts without DNase I treatment electrophoresed after denat-
uration showing the expected transcript size (6.5kb). The band
above the transcript band is the DNA template. Lane M: RNA
marker (Invitrogen, Calif, USA); 1, 2, 3: produced transcripts; M1:
1kb DNA ladder (Promega, Wis, USA); N: pCGT7X, ∼9.0kb;
D: DNA template, ∼6.5kb. There were traces of DNA template
detected in transcripts without DNase I treatment.
carrying EB4 with their respective priming sites are also as
indicatedinFigure 1.Thegenomesizeofwild-typeCGMMV
is approximately 6.4kb (without the plasmid backbone),
and the resulting chimeric CGMMV genome would be
approximately 6.5kb in size and contains the EB4 and read-
through sequences as well as inserted HindIII restriction
recognition sites and additional nucleotides enabling in-
frame cloning. The pRT and pRG chimeric clones were
constructed with the read-through sequence of TMV (CAA-
UAG-CAA-UUA). This leaky sequence meets the minimal
sequence requirement for eﬀective read-through of the stop
codon [12] and had been used successfully in previous
reports [14].
The templates for in vitro transcription of these two
clones were generated through LD-PCR (data not shown).
The resulting ampliﬁed products (∼6.5kb) consisted of a T7
promoterfusedwiththechimericCGMMVgenomecarrying
EB4. Transcripts produced from the two constructs were
separatelytestedforinfectivitybyinoculatingthehostplants.
After repeated attempts, both the pRT- and pRG-generated
transcripts did not cause infection of the inoculated plants
(Table 1). There was no evidence of virus genomic material
in the inoculated plant tissues tested (data not shown).
It is speculated that the read-through sequence of TMV
may not be suitable for the CGMMV chimeric clones,
hence contributing to the absence of infectious virus tran-
scripts. To overcome this possibility, another chimeric clone
(pCG+FSRTRE) was constructed using the read-through
sequence AAA-UAG-CAA-UUA of the wild-type CGMMV
itself (Figure 1). The template for in vitro transcription,
based on the pCG+FSRTRE clone, was generated through
LD-PCR. The in vitro transcription products (Figure 2)
were used in inoculation studies. The new leaves of plants4 Journal of Biomedicine and Biotechnology
Figure 3: Symptom appearance at 14 day-postinoculation (dpi) on
muskmelon plants caused by pCG+FSRTRE-derived transcripts.
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Figure 4: Gel image showing presence of ampliﬁed band (∼2.2kb)
after RT-PCR using PstI sense and reverse E primer. Lane M: 1kb
D N Al a d d e r( P r o m e g a ,W i s ,U S A ) ;1 – 8 :t o t a lR N Ae x t r a c t e df r o m
new noninoculated leaves of pCG+FSRTRE-derived transcripts
from infected plants; N: total RNA of new noninoculated leaves of
wild-type transcript from infected plants (negative control).
inoculated with pCG+FSRTRE-derived transcripts showed
evidence of virus infection with four out of eight plants
showing a typical symptom of CGMMV infection, which
include the green mottle mosaic appearance on day 14 pI
(Table 1 and Figure 3). Infection could be detected through
RT-PCRwhentotalRNAofnewnoninoculated leafwasused
as template. Detection of the virus by RT-PCR (Figure 4)
suggests that the viruses had moved from the inoculated
leaf to new leaves. This implies that the chimeric virus
pCG+FSRTRE carrying the read-through sequence from the
CGMMV genome (AAA-UAG-CAA-UUA) was infectious
and that the virus particles were able to assemble. The
plants, however, continued to grow without any further
noticeable symptoms. Virus particles were extracted from
the infected plants and an aliquot was electrophoretically
separated on 15% SDS-PAGE (Figure 5) resulting in two
distinct suggesting that the virus population consisted of two
species of coat proteins, the EB4-CP fusion (larger in size)
and the wild-type CGMMV CP (smaller in size). The ratio of
modiﬁed to unmodiﬁed CP was approximately 1:1.
3.2. Eﬀe c to fp I : C h a r g eV a l u eo nS t a b i l i t yo fC o n s t r u c t . Apart
from the usage of leaky UAG amber stop codons, it has been
reported that pI:charge can aﬀect the production of viable
recombinant virus [15]. The pI of the epitope is thought to
be an important factor as the hybrid coat protein pI:charge
value can aﬀect epitope presentation. It was also reported
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Figure 5: SDS-PAGE of puriﬁed chimeric virus coat protein (CP).
LaneM:proteinmarker(Fermantas);1:chimericvirus;2:wild-type
CGMMV.Itisclearlyshownthatthechimericvirusconsistedoftwo
diﬀerent CP species. The higher molecular band shows the EB4-
fusion CGMMV coat protein. The ratio of modiﬁed to unmodiﬁed
CP was approximately 1:1.
Table 1: Summary of experiments carried out to assess the
infectivity of diﬀerent transcript clones. (∗Total RNA was extracted
from new noninoculated leaves (third new leaf) of transcript
infected plants.)
Transcript
clones
Infectivity on
inoculated
plants
Symptom
appearance
∗Virus detected
through RT-PCR
pRT 0/6 Healthy No
pRG 0/6 Healthy No
pCG+FSRTRE 4/8 Green mottle
mosaic Yes
that TMV was more tolerant to positively charged epitopes
on its surface. Thus, it was initially speculated that the failure
in expression of the foreign peptide was possibly due to
the pI:charge value of recombinant CGMMV CP which was
diﬀerent from the wild-type CGMMV CP pI:charge value
(Table 2).
Table 2 shows the isoelectric point (pI) and charge of
the wild-type CGMMV CP, the read-through recombinant
CGMMV CP, and the EB4 insert. The charge of the EB4
insert is positive and potentially suitable for expression on
the surface of the CGMMV CP [2]. Hence, the inserted
peptide is speculated to be expressed if the pI:charge value of
modiﬁed virus CP resembles the pI:charge value of unmodi-
ﬁed virus CP. Earlier transcripts (data not shown) generated
from fusion clones without a read-through sequence, where
their pI values deviated signiﬁcantly (>6.0) from the wild-
type CP (5.08), were not able to cause infection in inoculated
plants leading to the suggestion initially that pI:charge valueJournal of Biomedicine and Biotechnology 5
1 EB4       
2 pCG+FSRTRE TTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAGCAATT
3 14 dpi     -----------------------------------------------------------------------------------GCTTCCAAATAGCAATT
4 21 dpi     TTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAGC----
5 30 dpi     TTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTNGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAG-----
6 wt CGMMV   TTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTT-------------
7 pCGT7X     TTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTT-------------
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
1 EB4        ATCATAGGAGTAGAGCCGGGACAATTGAAGCTCAACTGGTTTAAGAAAGGAAGTTCTATCGGCCAAATGATTGAGACAACAATGAGGGGAGCGAAGAGA
2 pCG+FSRTRE AATCATAGGAGTAGAGCCGGGACAATTGAAGCTCAACTGGTTTAAGAAAGGAAGTTCTATCGGCCAAATGATTGAGACAACAATGAGGGGAGCGAAGAGA
3 14 dpi     AATCATAGGAGTAGAGCCGGGACAATTGAAGCTCAACTGGTTTAAGAAAGGAAGTTCTATCGGCCAAATGATTGAGACAACAATGAGGGGAGCGAAGAGA
4 21 dpi     ----------------------------------------------------------------------------------------------------
5 30 dpi     ----------------------------------------------------------------------------------------------------
6 wt CGMMV   ----------------------------------------------------------------------------------------------------
7 pCGT7X     ----------------------------------------------------------------------------------------------------
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
1 EB4        ATGGCCATTTTAGGTGACACAGCTTGGGATTTTGGA
2 pCG+FSRTRE ATGGCCATTTTAGGTGACACAGCTTGGGATTTTGGAGAAGCTTAGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCCGTTC
3 14 dpi     ATG-CC---TTANG--------------------------------------------------------------------------------------
4 21 dpi     ---
---
---
---
--------------------TTGGGATTTTGGAGAAGCTTAGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCCGTTC
5 30 dpi     -----------------------------------------------TCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCCGTTC
6 wt CGMMV   -------------------------------------------AGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCCGTTC
7 pCGT7X     -------------------------------------------AGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCCGTTC
410 420 430 440 450 460 470 480 490 500
510 520 530 540 550 560 570 580 590 600
610 620 630 640 650 660 670 680 690 700
Sequence not determined
Deleted sequence
Gaps introduced for alignment
Figure 6: Sequence analyses of RT-PCR-ampliﬁed products from putative chimeric CGMMV RNA at diﬀerent days postinoculation (dpi).
The sequenced alignment shows that EB4 sequence was truncated and not complete after 21dpi. The putative chimeric CGMMV produced
did not express the EB4 and its genome resembled the wild-type CGMMV. Introduced read-through sequences and extra codons are
underlined. Complete EB4 sequence is aligned accordingly with the other sequences.
playedanimportantroleinvirusparticleassemblyandinfec-
tivity. Thus, the pI value of the recombinant CP constructs
was adjusted to more closely resemble the wild-type CP pI
value by inserting the acidic amino acid (glutamate) to the
3  end of CP (Table 2). The experiments (Table 1), however,
showed that although the pI was still higher than that of the
wild type (Table 2), the construct pCG+FSRTRE remained
infectious. This implies that infectivity of the clones was not
directlyrelatedtothedeviationinpIvaluewiththewild-type
virus CGMMV CP.
3.3. Deletion of Cloned Peptide Sequence. Sequencing was
carried out on RT-PCR-ampliﬁed products of viral RNA
extracted from putative chimeric virus particles at 30 days
postinoculation (dpi) and total plant RNA isolated from
inoculated plant materials at 14 and 21dpi to conﬁrm
the expression of EB4. Sequence analysis was done using
BioEdit Sequence Alignment Editor Software (version 6.0.5)
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The chi-
meric CP carried the complete EB4 sequence within its
genome at 14dpi (Figure 6). However, the EB4 sequence
appeared to be truncated at 21dpi with an upstream portion
of the EB4 sequence was not present. Only part of the
downstream sequence of EB4 was detected together with
the 3  untranslated region of the CGMMV. EB4 was totally
undetectable at 30dpi. Interestingly, the 5  e n do fi n tr od u c e d
read-through sequence (position 490 to 501) was retained
in the genome. The introduced HindIII recognition site at
EB4 downstream from position 639 to 644 wasfound to have
been deleted after 30dpi.
Even though only a single band was visible on RT-PCR
screening, it was suspected that there could be products with
similar sizes which could not be separated in normal agarose
gel electrophoresis, therefore, the RT-PCR products from the
chimeric CGMMV RNA at 30dpi were cloned into pGEM-
T Easy vector and subjected to sequence analyses. The results
(Figure 7)conﬁrmedtheabsenceoftheEB4sequence,except
for clone pR P3U4 (from nucleotide position of 702 to 746),
where only part of the downstream sequence of the EB4
was detected together with the 3  untranslated region of the
CGMMV. The 5  end of introduced read-through sequence
of AAA-TAG-CAA-TTA (position 594 to 605) was retained
within the genome for all sequenced clones (Figure 7). The
introduced HindIII site from position 742 to 747 was deleted
for clones pR P3U1, pR P3U3, and pR P3U11 after 30dpi.
The chimeric CGMMV sequence analyses showed one
common similarity (Figures 6 and 7), that is, that part of the
read-through amber stops codon sequence, and additional
nucleotides “CC-AAA-TAG” were retained for all sequenced
clones. This suggests that deletion had occurred within the
host plant. The sequence analysis also showed that the EB4
was not fully expressed in the putative chimeric CGMMV.6 Journal of Biomedicine and Biotechnology
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
EB4          
pCG+FSRTRE    TCTATTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAGC
pR_P3U1-M13R  TCTATTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAGC
pR_P3U3-M13R  TCTATTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAG-
pR_P3U4-M13R  TTTATTTGTAAGGGTTTTGATGTGTACGATAGGGCTTCATTTGAAGCCGTGTCTTCGGAAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAG-
pR_P3U11-M13R TCTATTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTTCCAAATAG-
pCGT7X        TCTATTTCTAAGGGTTTTGATGTTTACGATAGGGCTTCATTTGAAGCCGCGTTTTCGGTAGTCTGGTCAGAGGCTACCACCTCGAAAGCTT---------
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
EB4           ATCATAGGAGTAGAGCCGGGACAATTGAAGCTCAACTGGTTTAAGAAAGGAAGTTCTATCGGCCAAATGATTGAGACAACAATGAGGGGAGCGAA
pCG+FSRTRE    AATTAATCATAGGAGTAGAGCCGGGACAATTGAAGCTCAACTGGTTTAAGAAAGGAAGTTCTATCGGCCAAATGATTGAGACAACAATGAGGGGAGCGAA
pR_P3U1-M13R  ----------------------------------------------------------------------------------------------------
pR_P3U3-M13R  ----------------------------------------------------------------------------------------------------
pR_P3U4-M13R  ----------------------------------------------------------------------------------------------------
pR_P3U11-M13R ----------------------------------------------------------------------------------------------------
pCGT7X        ----------------------------------------------------------------------------------------------------
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
EB4           GAGAATGGCCATTTTAGGTGACACAGCTTGGGATTTTGGA
pCG+FSRTRE    GAGAATGGCCATTTTAGGTGACACAGCTTGGGATTTTGGAGAAGCTTAGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCC
pR_P3U1-M13R  ----------------------------------------------TAGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCC
pR_P3U3-M13R  ---------------------------------------------------TCGAGGGTCCTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCC
pR_P3U4-M13R  - AGAATGGCCATTTTAGGTGACACAGCTTGGGATTTTGGAGAAGCTTAGTTTTGAGGGTGTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCC
pR_P3U11-M13R ---------------------------------------------------TCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCC
pCGT7X        -----------------------------------------------AGTTTCGAGGGTCTTCTGATGGTGGTGCACACCAAAGTGCATAGTGCTTTCCC
510 520 530 540 550 560 570 580 590 600
610 620 630 640 650 660 670 680 690 700
710 720 730 740 750 760 770 780 790 800
---
---
Deleted sequence
Gaps introduced for alignment
Figure 7: Sequence alignments of cloned RT-PCR-ampliﬁed products from putative chimeric CGMMV RNA at 30dpi. Plasmid clones sent
for sequence analysis were pR P3U1, pR P3U3, pR P3U4, and pR P3U11. The sequence alignment shows that EB4 sequence was not within
the insert of plasmids, except for a partial sequence for pR P3U4 clone. Only part of the downstream sequence of EB4 was detected together
with 3  untranslated region of CGMMV for pR P3U4 clone, the rest were without EB4 sequence. Introduced read-through sequences and
extra codons are underlined. Complete EB4 sequence is aligned accordingly with the other sequences.
Table 2: Amino acid sequence, isoelectric point (pI) and charge of wild type, constructed recombinant CGMMV coat protein (CP), and the
EB4 insert.
Clones Amino acid sequence MW pI of CP Charge
(kDa) of CP
EB4 IIGVEPGQLKLNWFKKGSSIGQMIETTMRGAKRMAILGDT AWDFG 5.0 9.53 +1.9
MAYNPITPSKLIAFSASYVPVRTLLNFLVASQGTAFQTQAGRD
17.3 5.08 −3.1 Wild-type SFRESLSALPSSVVDINSRFPDAGFYAFLNGPVLRPIFVSLLSST
CGMMV DTRNRVIEVVDPSNPTTAESLNAVKRTDDASTAARAEIDNLIE
SISKGFDVYDRASFEAAFSVVWSEATTSKA
pRT∗
MAYNPITPSKLIAFSASYVPVRTLLNFLVASQGTAFQTQAGRD
23.0 5.41 −2.1
SFRESLSALPSSVVDINSRFPDAGFYAFLNGPVLRPIFVSLLSST
DTRNRVIEVVDPSNPTTAESLNAVKRTDDASTAARAEIDNLIE
SISKGFDVYDRASFEAAFSVVWSEATTSKACQQLIIGVEPGQ
LKLNWFKKGSSIGQMIETTMRGAKRMAILGDTAWDFGEA
pRG∗
MAYNPITPSKLIAFSASYVPVRTLLNFLVASQGTAFQTQAGRD
23.1 5.69 −1.1
SFRESLSALPSSVVDINSRFPDAGFYAFLNGPVLRPIFVSLLSST
DTRNRVIEVVDPSNPTTAESLNAVKRTDDASTAARAEIDNLIE
SISKGFDVYDRASFEAAFSVVWSEATTSKAWQQLIIGVEPGQ
LKLNWFKKGSSIGQMIETTMRGAKRMAILGDTAWDFGQA
pCG+FSRTRE∗
MAYNPITPSKLIAFSASYVPVRTLLNFLVASQGTAFQTQAGRD
22.9 5.41 −2.0
SFRESLSALPSSVVDINSRFPDAGFYAFLNGPVLRPIFVSLLSST
DTRNRVIEVVDPSNPTTAESLNAVKRTDDASTAARAEIDNLIE
SISKGFDVYDRASFEAAFSVVWSEATTSKASGQLIIGVEPGQ
LKLNWFKKGSSIGQMIETTMRGAKRMAILGDTAWDFGEA
∗With read-through leaky UAG amber stop codon.Journal of Biomedicine and Biotechnology 7
Table 3: Summary of sequence analyses carried out to conﬁrm
the presence of EB4 within the putative recombinant CGMMV. (#A
truncatedEB4sequencewasdetectedat30dpiaccordingtoFigure 7
for pR P3U4 clone from nucleotide position 702 to 746.)
Presence of EB4 within putative chimeric CGMMV genome
Sample
RNA source used for RT-PCR
Transcript-inoculated Virus particles
plant total RNA total RNA
14dpi 21dpi 30dpi
Chimeric clone
Present
Present in
#Not present (with pCG+FSRTRE <50% of
transcripts) plants tested
The positive results from the initial RT-PCR screening of
transcript-inoculated plants at 14dpi (Figure 4) suggest the
presence of EB4. The EB4 was, however, not detectable at
30dpi, and only present in some (< 50% tested) plants at
21dpi. These ﬁndings strongly suggest that deletion had
occurred within the host plants after 14dpi. The sequence
analyses in this section are summarized in Table 3.
4. Discussion
Plant virus vectors-based expression systems have been
widely studied for their development as antigen presentation
systems as well as for the production of pharmaceutically
important peptides. The CGMMV has been previously
shown to be suitable for expression of foreign peptide [7]. In
this study, CGMMV vector was used to express a 45 amino
acid EB4 gene. The integration of the EB4 gene into the end
of CGMMV coat protein gene was done via a leaky UAG
read-through sequence.
Transcripts generated from chimeric clones of pRT and
pRG carrying CAA-UAG-CAA-UUA read-through codon
sequences were not infectious. This is possibly caused by
the failure of self assembly [16] ,a n dt h u sn o n eo ft h e
inoculated plants was systemically infected. The assembly of
CGMMV into virus particle has been shown to be essential
for the viral movement through phloem [17], hence another
chimeric clone pCG+FSRTRE was constructed carrying
read-through sequence (AAA-UAG-CAA-UUA) from the
wild-type CGMMV genome. The clone containing this
read-through signal was infectious and produced chimeric
CGMMV(Table 1 andFigures4and5).Itis,thus,postulated
that there is a read-through signal preference between
diﬀerent species of tobamoviruses, in this case between TMV
andCGMMVcausingpossiblyviralparticleassemblyfailure.
It has also been shown that KGMMV, the tobamovirus,
whichhastheclosestgenomesimilaritytoCGMMV[13]also
utilizes the same CGMMV read-through signal reaﬃrming
the diﬀerences between the tobamoviruses. Additionally,
unlike other plant virus vectors [15, 18], this study reaﬃrms
that with CGMMV pI deviation did not appear to be a factor
aﬀecting infectivity [7].
The chimeric (carrying the EB4) and putative wild-type
CGMMV were shown to coexist in the virus population of
the infected plants (Figure 5). Previous reports show that the
eﬃciencies of the leaky UAG codon varied from 0.5% to
5% so that the ratio of modiﬁed to unmodiﬁed CP would
be between 1:200 and 1:20 [12, 19]. However, in this study,
relatively high levels of chimeric coat protein was observed
(Figure 5) giving a ratio of modiﬁed to unmodiﬁed CP of
approximately 1:1. It has been suggested that muskmelon
host plant could be producing higher levels of translation
nonsense suppressor tRNA making the application of the
translation read-through signal favorable in this host [7].
Due to their relatively higher rate of mutation during
replication, RNA viruses are evolving rapidly and this is
the basis of their ubiquity and adaptability [20, 21]. In
this study, it is shown that the EB4 gene sequence carried
by the chimeric CGMMV was systemically removed during
the infection process. The order of the removal of the
transgene was speculated to be the 5  to 3  direction (Figures
6 and 7). This is further supported by the detection of
two additional nucleotides together with the read-through
sequence “CC-AAA-TAG” downstream from the CGMMV
CP ORF. This report shows the temporal in-host truncation
of the transgene from a chimeric virus in a natural host.
Recent report has shown truncation occurring in transgenic
plants expressing the same or similar transgenes as the
chimeric virus [22] suggesting targeting by a resistance
mechanism or competition with the parental virus as the
mechanism involved. The exact mechanism of truncation
of the transgene in our study is less clear as a previous
study using the same vector and host with a diﬀerent
transgene did not exhibit the same instability [7]. The
larger size of the EB4 peptide in comparison to the
Hepatitis B epitope, however, suggests that the truncation
mechanism or transgene recognition by the virus was size
dependent.
In summary, we have shown that CGMMV has a read-
through codon preference and that the read-through codon
for TMV was shown to be not eﬃcient, as the chimeric
CGMMV transcripts utilizing this signal were not infectious.
The reported limitation of low-modiﬁed coat protein yield
of this type of read-through transient expression system
appears to have been overcome as relatively equal yield
of chimeric and wild-type CGMMV coat protein were
produced. This report also provides a rational harvest-
ing timeline for the chimeric virus making this system
exploitable for implementation in a plantation scale in
the future. It can be suggested that once host plants are
infected with the chimeric virus carrying the inserted foreign
peptides, the optimum harvesting time would be at around
14dpi or not more than 20dpi in order to obtain maximum
yield of the full-length transgene. Growth of the infected
plants for longer periods to obtain higher yields of the
chimeric virus may induce unwanted transgene deletions.
This and other factors described earlier should be relevant
information for the further development of CGMMV or
other plant viruses as vectors for medically important
peptides such as for dengue (this study) and Hepatitis B [7]
viral antigens.8 Journal of Biomedicine and Biotechnology
Acknowledgments
The authors thank Ministry of Science, Technology and
Innovation of Malaysia (Grant no. 36-02-03-6003) and the
University of Malaya for ﬁnancial support, and Dr. Siang-
HeeTanforthemuskmelonseedsusedinthestudy.Aspecial
thankstoDr.PeterPalukaitis(SCRI)forhiscommentsonthe
manuscript.
References
[ 1 ]J .M .A l a m i l l o ,W .M o n g e r ,I .S o l a ,e ta l . ,“ U s eo fv i r u sv e c t o r s
for the expression in plants of active full-length and single
chain anti-coronavirus antibodies,” Biotechnology Journal, vol.
1, no. 10, pp. 1103–1111, 2006.
[2] Y. Gleba, V. Klimyuk, and S. Marillonnet, “Viral vectors for
the expression of proteins in plants,” Current Opinion in
Biotechnology, vol. 18, no. 2, pp. 134–141, 2007.
[3] J. Johnson, T. Lin, and G. Lomonossoﬀ, “Presentation of
heterologous peptides on plant viruses: genetics, structure,
and function,” Annual Review of Phytopathology, vol. 35, pp.
67–86, 1997.
[4] C. Lacomme, L. Smolenska, and T. M. A. Wilson, “Genetic
engineering and the expression and the expression of foreign
peptides or proteins using plant virus-based vectors,” in
Genetic Engineering: Principles and Methods,J .K .S e t l o w ,E d . ,
vol. 20, pp. 225–237, Plenum Press, New York, NY, USA, 1988.
[5] C. Porta and G. P. Lomonossoﬀ, “Scope for using plant
viruses to present epitopes from animal pathogens,” Reviews
in Medical Virology, vol. 8, no. 1, pp. 25–41, 1998.
[6] K. Dalsgaard, ˚ A. Uttenthal, T. D. Jones, et al., “Plant-derived
vaccine protects target animals against a viral disease,” Nature
Biotechnology, vol. 15, no. 3, pp. 248–252, 1997.
[ 7 ]A .O o i ,S .T a n ,R .M o h a m e d ,N .A b d u lR a h m a n ,a n dR .Y .
Othman, “The full-length clone of cucumber green mottle
mosaic virus and its application as an expression system for
Hepatitis B surface antigen,” Journal of Biotechnology, vol. 121,
no. 4, pp. 471–481, 2006.
[ 8 ]A .A .B r u n t ,K .C r a b t r e e ,M .J .D a l l w i t z ,A .J .G i b b s ,L .
Watson, and E. J. Zurcher, “Cucumber green mottle mosaic
tobamovirus,” Plant Viruses Online: Descriptions and Lists
from the VIDE Database, 1996, http://image.fs.uidaho.edu/
vide/descr265.htm.
[9] M. Ugaki, M. Tomiyama, T. Kakutani, et al., “The complete
nucleotide sequence of cucumber green mottle mosaic virus
(SH strain) genomic RNA,” Journal of General Virology, vol.
72, no. 7, pp. 1487–1495, 1991.
[10] L. van Vloten-Doting, J.-F. Bol, and B. Cornelissen, “Plant-
virus-based vectors for gene transfer will be of limited
use because of the high error frequency during viral RNA
synthesis,” Plant Molecular Biology, vol. 4, no. 5, pp. 323–326,
1985.
[11] H. Wang and G. Stubbs, “Structure determination of cucum-
ber green mottle mosaic virus by X-ray ﬁber diﬀraction.
Signiﬁcance for the evolution of tobamoviruses,” Journal of
Molecular Biology, vol. 239, no. 3, pp. 371–384, 1994.
[12] J. M. Skuzeski, L. M. Nichols, R. F. Gesteland, and J. F. Atkins,
“ThesignalforaleakyUAGstopcodoninseveralplantviruses
includes the two downstream codons,” Journal of Molecular
Biology, vol. 218, no. 2, pp. 365–373, 1991.
[13] S.-H. Tan, M. Nishiguchi, M. Murata, and F. Motoyoshi, “The
genome structure of kyuri green mottle mosaic tobamovirus
and its comparison with that of cucumber green mottle
mosaic tobamovirus,” Archives of Virology, vol. 145, no. 6, pp.
1067–1079, 2000.
[14] Y. Sugiyama, H. Hamamoto, S. Takemoto, Y. Watanabe, and
Y. Okada, “Systemic production of foreign peptides on the
particle surface of tobacco mosaic virus,” FEBS Letters, vol.
359, no. 2-3, pp. 247–250, 1995.
[15] M. Bendahmane, M. Koo, E. Karrer, and R. N. Beachy,
“Display of epitopes on the surface of tobacco mosaic virus:
impact of charge and isoelectric point of the epitope on virus-
host interactions,” Journal of Molecular Biology, vol. 290, no. 1,
pp. 9–20, 1999.
[16] V. Yusibov, A. Modelska, K. Steplewski, et al., “Antigens
produced in plants by infection with chimeric plant viruses
immunize against rabies virus and HIV-1,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 94, no. 11, pp. 5784–5788, 1997.
[17] L. Sim´ on-Buela and F. Garc´ ıa-Arenal, “Virus particles of
cucumber green mottle mosaic tobamovirus move systemi-
cally in the phloem of infected cucumber plants,” Molecular
Plant-Microbe Interactions, vol. 12, no. 2, pp. 112–118, 1999.
[18] K. Uhde-Holzem, R. Fischer, and U. Commandeur, “Genetic
stability of recombinant potato virus X virus vectors present-
ing foreign epitopes,” Archives of Virology, vol. 152, no. 4, pp.
805–811, 2007.
[19] H. R. B. Pelham, “Translation of tobacco rattle virus RNAs in
vitro: four proteins from three RNAs,” Virology, vol. 97, no. 2,
pp. 256–265, 1979.
[20] E. D. Kilbourne, “New viruses and new disease: mutation,
evolution and ecology,” Current Opinion in Immunology, vol.
3, no. 4, pp. 518–524, 1991.
[21] E. Domingo and J. J. Holland, “RNA virus mutations and
ﬁtness for survival,” Annual Review of Microbiology, vol. 51,
pp. 151–178, 1997.
[22] B.-N.Chung,T.Canto,andP.Palukaitis,“Stabilityofrecombi-
nantplantvirusescontaininggenesofunrelatedplantviruses,”
JournalofGeneralVirology,vol.88,no.4,pp.1347–1355,2007.